Ascendis Pharma A/S
ASND
5 insider filings · Latest: Jun 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Jun 2 4:25 PM | Scott Thomas SmithEVP & Chief Financial Officer | Purchase | 100 | $219.00 | $21.9K | 4,367(D) | View → |
| May 29, 2026 | Jun 1 4:11 PM | Jean Jacques BienaimeDirector | Purchase | 500 | $223.12 | $111.6K | 900(D) | View → |
| May 29, 2026 | Jun 1 4:10 PM | Scott Thomas SmithEVP & Chief Financial Officer | Purchase | 250 | $223.32 | $55.8K | 4,267(D) | View → |
| May 26, 2026 | May 27 4:05 PM | Jean Jacques BienaimeDirector | Purchase | 400 | $237.80 | $95.1K | 400(D) | View → |
| May 11, 2026 | May 12 4:08 PM | Flemming Steen JensenEVP & Product Supply and Quality | Sale | 19,460 | $238.49 | $4.6M | 0(D) | View → |
Stock Options & Derivatives
No transactions found.